You are here

Sanofi eyes approval of Covid-19 vaccine by first half of 2021

AB_sanofi_230620.jpg
French drugmaker Sanofi SA said on Tuesday it expects to get approval for the potential Covid-19 vaccine it is developing with Britain's GlaxoSmithKline Plc by the first half of next year, faster than previously anticipated.

[PARIS] French drugmaker Sanofi SA said on Tuesday it expects to get approval for the potential Covid-19 vaccine it is developing with Britain's GlaxoSmithKline Plc by the first half of next year, faster than previously anticipated.

Sanofi, which is hosting a virtual research and...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes